文献速递腹部介入USCT

影像引导下双次经皮穿刺抽吸注射术与手术治疗肝囊型棘球蚴病的比较

A comparison of imaging guided double percutaneous aspiration injection and surgery in the treatment of cystic echinococcosis of liver.
PubMed 文献 · Br J Radiol · 2017-03-07

研究将43例肝囊型棘球蚴病患者随机分为双次经皮穿刺抽吸注射术组(22例)和手术组(21例),随访3年。双次经皮穿刺抽吸注射术组平均住院2.38天,手术组8.23天;以10%非劣效界值,双次经皮穿刺抽吸注射术组治疗反应非劣于手术组,且住院时间和并发症发生率差异有统计学意义。

要点

  • 双次经皮穿刺抽吸注射术组成功率为95.3%(20/22),手术组成功率为85.7%(18/21)。
  • 双次经皮穿刺抽吸注射术组平均住院2.38天,手术组8.23天。
  • 手术组主要并发症发生率为28.57%(6/21),双次经皮穿刺抽吸注射术组为4.7%(1/22)。

核心结论

  • 随访3年,双次经皮穿刺抽吸注射术治疗肝囊型棘球蚴病非劣于手术,且住院时间和并发症发生率的差异有统计学意义。

研究设计与样本

  • 随机对照研究,纳入2012年11月至2015年11月43例患者,随机分为双次经皮穿刺抽吸注射术组(n=22)和手术组(n=21),术后前3个月每月评估,第6个月及此后每6个月评估。

诊断标准与关键数值

  • 双次经皮穿刺抽吸注射术组治疗反应成功95.3%(n=20)、不完全4.7%(n=1);手术组成功85.7%(n=18)、不完全4.7%(n=1)、复发9.5%(n=2);采用10%非劣效界值,双次经皮穿刺抽吸注射术组治疗反应非劣于手术组。

临床应用与阅片要点

  • 双次经皮穿刺抽吸注射术具有住院时间短、微创和并发症少的优点,且非劣于手术;总免疫球蛋白G抗体滴度在治疗随访中 utility 有限。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To compare the results and complications of treatment by double percutaneous aspiration injection (DPAI) in cystic echinococcosis (CE) of the liver with those of surgery. To the best of our knowledge, such a study has not been carried out till date.

METHODS: From November 2012 to November 2015, 43 patients were randomly allocated to DPAI group (n = 22) and surgery group (n = 21). After the intervention, patients were evaluated monthly for 3 months, then at the sixth month and 6 monthly thereafter.

RESULTS: Average hospital stay was 2.38 days in DPAI group and 8.23 days in the surgery group. Response to DPAI was categorized as successful in 95.3% (n = 20) patients and incomplete in 4.7% (n = 1) patients. Response to surgery was characterized as successful in 85.7% (n = 18) patients and incomplete in 4.7% (n = 1) patients, and recurrence was seen in 9.5% (n = 2) patients. Using a 10% margin for non-inferiority, treatment response in the DPAI group was non-inferior to that of the surgery group. In the DPAI group, 19 patients had no complications, minor complications were seen in 4.7% (n = 1) patients and a major complication was seen in 4.7% (n = 1) patients. In the surgery group, no complications were seen in 13 patients, major complications were seen in 28.57% (n = 6) patients and minor complications were seen in 9.5% (n = 2) patients.

CONCLUSION: Over a follow-up period of 3 years, DPAI is non-inferior to surgery in the treatment of CE of the liver, while there is a statistically significant difference in the hospital stay and occurrence of complications. Advances in knowledge: DPAI offers advantages such as a short hospital stay, minimal invasiveness and morbidity, while being non-inferior to surgery. Total Immunoglobulin G antibody titres have limited utility in follow-up of patients treated.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Shera TA, Choh NA, Gojwari TA, et al. A comparison of imaging guided double percutaneous aspiration injection and surgery in the treatment of cystic echinococcosis of liver. Br J Radiol. 2017. PMID: 28124569. doi:10.1259/bjr.20160640

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。